Andrea Day, ARNP
NPI 1669747473 · Psychiatric/Mental Health Nurse Practitioner · Chewelah, WA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1669747473
- Entity type
- Individual
- Primary specialty
- Psychiatric/Mental Health Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- ARNP
- Sex
- Female
- Sole proprietor
- Yes
- License
- 62493 (ID)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Physician Assistants & Advanced Practice Nursing Providers
Nursing Service Providers
Physician Assistants & Advanced Practice Nursing Providers
Nursing Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
14 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Clonidine Hcl | 82 | 58 |
| Hydroxyzine Pamoate | 67 | 54 |
| Trazodone Hcl | 57 | 46 |
| Methocarbamol | 52 | 43 |
| Ondansetronbrand: Ondansetron Odt | 48 | 44 |
| Promethazine Hcl | 44 | 42 |
| Dicyclomine Hcl | 43 | 41 |
| Buprenorphine Hcl/Naloxone Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$745 across 20 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2012-03-12
- Last updated
- 2025-10-30
- Certified
- 2025-10-30
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.